Two stories in Nature this week bracket the same anxiety from different directions. European researchers are actively migrating off US tech infrastructure, citing geopolitical instability and data sovereignty concerns. And scientists have achieved the first precise genome editing of human embryos, triggering simultaneous praise and alarm from the bioethics community. Both events are about who controls foundational systems. Both are being shaped by the same political pressures that are making the DOGE breach and the Trump-OpenAI equity conversation feel inevitable.
Sovereignty as the New Platform Strategy
When European researchers leave AWS and Google Cloud, they are not making a technical decision. They are making a political one. The infrastructure of science, where data lives, who can subpoena it, what terms of service govern it, is now explicitly a geopolitical question. The same logic applies to genome editing. The first precise embryo edit triggers alarm not primarily because of what was done, but because of who gets to decide what gets done next. Sovereignty over the genome and sovereignty over research infrastructure are both versions of the same question: which institutions, under which legal frameworks, hold the power to shape biological and epistemic futures.
The Accelerationist Funding Gap
Here is where the business story enters. The European tech exit creates immediate infrastructure demand: sovereign cloud, local compute, data residency solutions. The genome editing breakthrough creates immediate bioethics governance demand and, in parallel, investment opportunity. TurboFund's biotech VC list captures the investors already positioned at this intersection, many of whom are watching the governance debate closely because regulatory frameworks will determine which applications get commercialized first. A 2025 paper in Nature Biotechnology by Hank Greely found that the 36-month window following a major editing milestone is when the most consequential governance decisions are made, typically by people who did not expect to be making them. The EV data point is worth holding alongside this: electric vehicles in China prevented 260,000 premature deaths according to new Nature research, a reminder that the technologies we govern well at formation stage have compounding returns at scale. The ones we do not govern, we inherit as crises.